Feline babesiosis.
OBJECTIVE
To review and summarize current information regarding the etiology, clinical presentation, diagnosis, treatment, and prognosis of feline babesiosis, especially with regard to features distinct from canine babesiosis.


BACKGROUND
Babesiosis is caused by hemoprotozoa of the genus Babesia. Numerous species of Babesia exist worldwide. The babesial organism spends the majority of its life cycle within the erythrocyte of the definitive host, resulting in hemolysis, with or without systemic complications.


METHODS
Definitive diagnosis depends on direct visualization of the organism on blood smear or a positive polymerase chain reaction. Positive serologic tests indicate only exposure, with or without active infection.


METHODS
Antiprotozoal drugs and supportive care are the mainstays of therapy. Primaquine phosphate is considered the treatment of choice in cats.


CONCLUSIONS
Prognosis depends on the severity of disease, which in turn depends on both organism and host factors. Mortality rates of 15-20% are reported.
Department of Emergency and Critical Care Medicine, Animal Medical Center, 510 East 62nd St, New York, NY 10065, USA. ashley.ayoob@amcny.org
Ashley L
AL
Ayoob
Jennifer
J
Prittie
Susan G
SG
Hackner
D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001403:Babesia / Q000302:isolation & purification / Q000472:pathogenicity; D001404:Babesiosis / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000662:veterinary*; D002371:Cat Diseases / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D002415:Cats; D008018:Life Cycle Stages; D011379:Prognosis; D012307:Risk Factors; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000981:Antiprotozoal Agents